Highest Impacted Articles

SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

RICH, RYAN M.; ROSENFELD, PHILIP J.; PULIAFITO, CARMEN A.; More

RETINA. 26(5):495-511, May-June 2006.

ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)

SHAHAR, JONATHAN; AVERY, ROBERT L.; HEILWEIL, GAD; More

RETINA. 26(3):262-269, March 2006.

TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)

MANZANO, ROBERTA P. A.; PEYMAN, GHOLAM A.; KHAN, PALWASHA; More

RETINA. 26(3):257-261, March 2006.

INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF MACULAR EDEMA IN CENTRAL RETINAL VEIN OCCLUSION: A Short-Term Study

ITURRALDE, DIANA; SPAIDE, RICHARD F.; MEYERLE, CATHERINE B.; More

RETINA. 26(3):279-284, March 2006.

INTRAVITREAL BEVACIZUMAB (AVASTIN) THERAPY FOR PERSISTENT DIFFUSE DIABETIC MACULAR EDEMA

HARITOGLOU, CHRISTOS; KOOK, DANIEL; NEUBAUER, ALJOSCHA; More

RETINA. 26(9):999-1005, November-December 2006.

INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)

JORGE, RODRIGO; COSTA, ROGÉRIO A.; CALUCCI, DANIELA; More

RETINA. 26(9):1006-1013, November-December 2006.

DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

FERRARA, NAPOLEONE; DAMICO, LISA; SHAMS, NAVEED; More

RETINA. 26(8):859-870, October 2006.